Rising Pharmaceuticals has voluntarily recalled 2,220 bottles of Methylphenidate Hydrochloride chewable tablets (2.5 mg), a medication used to treat ADHD. The recall was issued after two reports were received of a tablet in a sealed bottle being twice the size of the other tablets. Consuming an oversized tablet would result in a patient receiving double the intended dose of medication. These 100-count bottles were distributed to pharmacies nationwide across the United States.
An oversized tablet contains twice the intended amount of medication, which can lead to an accidental overdose and serious adverse health effects. While no injuries have been reported to date, the manufacturer is recalling the product to prevent potential harm from failed dosage specifications.
You have 2 options:
Manufactured for: Rising Pharmaceuticals Inc., Saddle Brook, NJ 07863. Recall #: D-0573-2022.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.